Global TB Research Funding Continues to Fall Short
December 4, 2018 – NEW YORK – Though global funding for tuberculosis (TB) research is beginning to move in the
Press Releases
TB Alliance Receives GHTC Partnership Award for Development of Child-Friendly TB Medicines
[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health
Closing the TB Funding Gap
Project Syndicate Op-Ed by Willo Brock, SVP External Affairs, TB Alliance NEW YORK – In the 25 years since tuberculosis
TB Alliance Statement on EMA Approval of Fexinidazole
November 19, 2018 – NEW YORK – TB Alliance congratulates DNDi and its partners on receiving a positive scientific opinion of
TB Alliance Joins Innovative Medicines Initiative to Accelerate Development of New TB Cures
[October 24, 2018, NEW YORK] – TB Alliance has joined the Innovative Medicines Initiative (IMI) as an Associated Partner on
Statement on UN High-Level Meeting on TB
NEW YORK (September 26, 2018) It has been 25 years since tuberculosis (TB) was declared a global emergency by the World
TB Alliance and Liverpool School of Tropical Medicine Collaborate to Develop New TB Therapies
LIVERPOOL (September 19, 2018) – The Liverpool School of Tropical Medicine (LSTM) and TB Alliance are collaborating to investigate novel
Once Again, New TB Numbers Underscore the Need for New Treatments
Tuberculosis (TB) is still the world’s deadliest infectious disease, as reported today by the World Health Organization (WHO). Last year
SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia
NEW YORK, NY (August 28, 2018)—TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
TB Alliance congratulates the World Health Organization on the issuance of its rapid communication informing all stakeholders about the key